Cargando…
Evaluation of Infection Risk Factors in Adult Hematologic Malignancy Patients
INTRODUCTION: Hematologic malignancies (HM) are often highly aggressive processes requiring multi-chemotherapy regimens and potentially hematopoietic stem cell transplant (HSCT) for treatment. Totally implantable venous access ports (TIVAP) are the standard access for administration of these regimen...
Autores principales: | Peterson, Shawn Lanham, Priddy, Erin, Dong, Brian Yang, Ghazi, Cameron Alexander, Dinglasan, Lu Anne Velayo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128306/ http://dx.doi.org/10.1016/j.bbmt.2018.12.562 |
Ejemplares similares
-
Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022) -
Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023) -
Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020) -
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
por: Pagano, Livio, et al.
Publicado: (2021) -
Characteristics of pathogens detected in adults with hematological malignancies and nosocomial infections in the tropics
por: Dou, Li-Ping, et al.
Publicado: (2020)